Skip to main content

Table 5 Internal consistency reliability of the FH KAP questionnaire

From: Validity and reliability of an adapted questionnaire measuring knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in Malaysia

Item No Area of KAP regarding FH KR-20 Overall KR-20
Knowledge domain 0.79
3 Description of FH 0.53
4 Identification of lipid profile in FH
6 Prevalence of FH globally
7 Transmission of FH to first-degree relative
8 Rate of CAD risk in untreated FH
9 Age threshold for premature CAD
11 Genetic test for diagnosis of FH
22 Target LDL-c in FH
23 Important family history in FH
24 Exclusion of the diagnosis of FH
25 Management options in FH
Awareness domain  
1 Familiarity with FH 0.76
2 Awareness of NICE clinical guideline
15 Awareness of lipid specialist
19 Awareness of other FH clinical guidelines
20 Awareness of FH diagnostic criteria
Practice domain  
5 Assistance in detection of FH 0.61
10 Screening for FH in premature CAD
12 Family screening in FH patients
13 Most effective healthcare provider to detect FH and screen first-degree relatives
14 Age of FH screening among young person
17 Pharmacotherapy used for hypercholesterolaemia
18 Combined pharmacotherapy used for severe hypercholesterolaemia
21 CAD risk stratification in FH
  1.  FH, familial hypercholesterolaemia; CAD, coronary artery disease; LDL-c, low density lipoprotein cholesterol; NICE, National Institute for Health and Care Excellence;